Click to Share

Filter News
Show All Results
News By Country
News By Tag
Ulcerative Colitis Remove

January 2023

Public Company News

Business Press Releases

Ulcerative Colitis Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Vivisum Partners, LLC
Despite its strong efficacy, Remicade is facing increased competition from newer drugs and the prospect of pipeline drugs set to launch in the coming years.
By Vivisum Partners, LLC
Among branded ulcerative colitis treatments, 84% of US gastroenterologists expect Zeposia to see an increase in prescription volume over the next 12 months, according to new research on the ulcerative colitis marketplace published by Vivisum Partners.
By Vivisum Partners, LLC
New research into ulcerative colitis pipeline drugs found that US gastroenterologists who treat irritable bowel disease (IBD) have low awareness of some developing therapies.
By Vivisum Partners
Newly published research found that several new ulcerative colitis drugs currently in development are providing excitement among gastroenterologists eager to add additional medicines to their current treatment options.

Page updated every 10 minutes

Like PRLog?
Click to Share